News » MHRA alert » Alerts: Baclofen 10mg/5ml oral solution, ibuprofen 200mg tablets
February 5th 2026
Syri Limited, T/A SyriMed is recalling two batches of Baclofen 10mg/5ml Oral Solution.
|
Batch No. |
Expiry Date |
Pack Size |
First Distributed |
|
EBB25001A1 |
31/03/2027 |
150ml |
30/07/2025 |
|
EBB24001A1 |
30/09/2026 |
150ml |
17/02/2025 |
This is a precautionary measure due to a potential risk of sub-therapeutic dosing.
Healthcare professionals are asked to quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Patients should continue to take medicines from these batches as prescribed by your healthcare professional.
For medical information enquiries please use the following options:
Email: medinfo@syrimed.co.uk, or telephone +44 (0) 330 1359 422.
For stock control enquiries please email syriwholesale@bnsthamelabs.com
In addition, four batches of Aspar, Almus and Numark branded ibuprofen 200mg tablets are being recalled.
The affected batches are:
|
Batch No. |
Expiry Date |
Pack Size |
First Distributed |
|
250135 Almus |
31/12/2026 |
24 |
18/06/2025 |
|
250399 Almus |
30/06/2027 |
24 |
04/08/2025 |
|
250125 Numark |
31/12/2026 |
24 |
27/05/2025 |
|
250109 Aspar |
31/12/2026 |
48 |
25/03/2025 |
This is a precautionary measure following findings of foil perforations in some blisters. Healthcare professionals are asked to quarantine all stock and return it to your supplier using your supplier’s approved process.
Patients should continue to take medicines from these batches as prescribed by your healthcare professional.
For all enquiries regarding this product, please call 020 8205 9846 extension 2209 or email adrian.zahra@aspar.co.uk.
